Aptose Biosciences Inc. announced that, at the Company’s annual and special meeting of shareholders held today, May 23, 2023, the proposed reverse stock split of the Company’s common shares, as described in the proxy statement dated April 18, 2023, was approved by 93.44% of the votes cast at the Meeting.
May 23, 2023
· 8 min read